, and it supports the utility of a diverse library of CRBN binders in the pursuit of targeting undruggable oncoproteins.
No takes yet. Share an insight, caveat, or question.
Nishiguchi et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: